112 related articles for article (PubMed ID: 25023895)
1. Effects of silencing connexin43 on expression of pituitary tumor-transforming gene in prolactinomas.
Wang H; Zhang Y; Zhou A; Zhang R; Meng Q
Neurol Res; 2015 Feb; 37(2):153-8. PubMed ID: 25023895
[TBL] [Abstract][Full Text] [Related]
2. Effects of inhibiting connexin43 on expression of fibroblast growth factor in prolactinomas in rats.
Wang H; Gao B; Zhang Y; Xu H
Neurol Res; 2016 May; 38(5):456-60. PubMed ID: 27078698
[TBL] [Abstract][Full Text] [Related]
3. PTTG expression in different experimental and human prolactinomas in relation to dopaminergic control of lactotropes.
Cristina C; Díaz-Torga GS; Goya RG; Kakar SS; Perez-Millán MI; Passos VQ; Giannella-Neto D; Bronstein MD; Becu-Villalobos D
Mol Cancer; 2007 Jan; 6():4. PubMed ID: 17222350
[TBL] [Abstract][Full Text] [Related]
4. Strain difference in regulation of pituitary tumor transforming gene (PTTG) in estrogen-induced pituitary tumorigenesis in rats.
Yin H; Fujimoto N; Maruyama S; Asano K
Jpn J Cancer Res; 2001 Oct; 92(10):1034-40. PubMed ID: 11676853
[TBL] [Abstract][Full Text] [Related]
5. Functional role of estrogen in pituitary tumor pathogenesis.
Heaney AP; Fernando M; Melmed S
J Clin Invest; 2002 Jan; 109(2):277-83. PubMed ID: 11805140
[TBL] [Abstract][Full Text] [Related]
6. [Analysis of different mutations in regulatory sequence of prolactin gene during the formation of 17 beta-estradiol-induced prolactinoma in eutopic and ectopic pituitary of rats].
Zhang FZ; Yang QH; Mao YC; Xu RK
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Dec; 28(6):822-7. PubMed ID: 17260475
[TBL] [Abstract][Full Text] [Related]
7. Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis.
Heaney AP; Horwitz GA; Wang Z; Singson R; Melmed S
Nat Med; 1999 Nov; 5(11):1317-21. PubMed ID: 10546001
[TBL] [Abstract][Full Text] [Related]
8. [Expression of prolactin, TGF alpha and TGF beta 1 genes in estrogen-induced eutopic and ectopic pituitary prolactin-secreting tumors of rats].
Wu XM; Xu JP; Zhang R; Xu RK
Sheng Li Xue Bao; 1999 Dec; 51(6):675-80. PubMed ID: 11498938
[TBL] [Abstract][Full Text] [Related]
9. Pituitary tumor transforming gene (PTTG) expression in pituitary adenomas.
Zhang X; Horwitz GA; Heaney AP; Nakashima M; Prezant TR; Bronstein MD; Melmed S
J Clin Endocrinol Metab; 1999 Feb; 84(2):761-7. PubMed ID: 10022450
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of estrogen and estrogen receptor antagonist, ICI 182 780, on the expression of calbindin-D9k in rat pituitary prolactinoma GH₃ cells.
Wang W; Knosp E; Tai G; Zhao Y; Liang Q; Guo Y
Int J Clin Exp Pathol; 2014; 7(12):8498-505. PubMed ID: 25674214
[TBL] [Abstract][Full Text] [Related]
11. Pituitary gene expression differs in D-galactose-induced cell senescence and steroid-induced prolactinomas.
Zhang T; Zhao B; Li J; Zhang C; Li H; Wu J; Zhang S; Hui G
Mol Med Rep; 2015 Apr; 11(4):3027-32. PubMed ID: 25482089
[TBL] [Abstract][Full Text] [Related]
12. The role of TGF-β/Smad signaling in dopamine agonist-resistant prolactinomas.
Li Z; Liu Q; Li C; Zong X; Bai J; Wu Y; Lan X; Yu G; Zhang Y
Mol Cell Endocrinol; 2015 Feb; 402():64-71. PubMed ID: 25578603
[TBL] [Abstract][Full Text] [Related]
13. Estradiol-induced prolactinomas: differential effects on dopamine in posterior pituitary and median eminence.
Burgett RA; Garris PA; Ben-Jonathan N
Brain Res; 1990 Oct; 531(1-2):143-7. PubMed ID: 2289118
[TBL] [Abstract][Full Text] [Related]
14. Sex differences in the development of prolactinoma in mice overexpressing hCGβ: role of TGFβ1.
Faraoni EY; Camilletti MA; Abeledo-Machado A; Ratner LD; De Fino F; Huhtaniemi I; Rulli SB; Díaz-Torga G
J Endocrinol; 2017 Mar; 232(3):535-546. PubMed ID: 28096433
[TBL] [Abstract][Full Text] [Related]
15. Genes differentially expressed in prolactinomas responsive and resistant to dopamine agonists.
Passos VQ; Fortes MA; Giannella-Neto D; Bronstein MD
Neuroendocrinology; 2009; 89(2):163-70. PubMed ID: 18791324
[TBL] [Abstract][Full Text] [Related]
16. Effects of estrogen receptor antagonist on biological behavior and expression of growth factors in the prolactinoma MMQ cell line.
Lv H; Li C; Gui S; Sun M; Li D; Zhang Y
J Neurooncol; 2011 Apr; 102(2):237-45. PubMed ID: 20700755
[TBL] [Abstract][Full Text] [Related]
17. [Melatonin inhibits the proliferation of pituitary prolactin-secreting tumor by suppressing the enhancer elements mutation of PRL gene in the rat].
Gao L; Yang QH; Xu RK
Sheng Li Xue Bao; 2005 Jun; 57(3):319-27. PubMed ID: 15968426
[TBL] [Abstract][Full Text] [Related]
18. Pattern of FGF-2 isoform expression correlated with its biological action in experimental prolactinomas.
Mukdsi JH; De Paul AL; Petiti JP; Gutiérrez S; Aoki A; Torres AI
Acta Neuropathol; 2006 Oct; 112(4):491-501. PubMed ID: 16823503
[TBL] [Abstract][Full Text] [Related]
19. [Melatonin suppressing the proliferation of E2-induced pituitary prolactin-secreting tumor in rat involves the effects of estrogen receptor].
Yang QH; Xu JN; Zhang R; Gao L; Xu RK
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2006 May; 22(2):174-8. PubMed ID: 21162234
[TBL] [Abstract][Full Text] [Related]
20. Lindane, a gap junction blocker, suppresses FSH and transforming growth factor beta1-induced connexin43 gap junction formation and steroidogenesis in rat granulosa cells.
Ke FC; Fang SH; Lee MT; Sheu SY; Lai SY; Chen YJ; Huang FL; Wang PS; Stocco DM; Hwang JJ
J Endocrinol; 2005 Mar; 184(3):555-66. PubMed ID: 15749814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
